Poland· PL-100475890

Stygmistanon

A pyridostigmine product containing pyridostigmini bromidum, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 16 of our 19 countries.

ATC N07AA02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pyridostigmini bromidumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pyridostigmine is registered in 16 of 19 countries.

Countries holding a registration under ATC N07AA02 (pyridostigmine), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search pyridostigmine products by name

Pyridostigmine · ATC N07AA02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pyridostigmine costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Pyridostigmine · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

CH Switzerland$2.06
FR France$1.63

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Pyridostigmini bromidum
Manufacturer: STADA Arzneimittel AG
Country: Poland (PL)
ATC code: N07AA02
ATC class: Pyridostigmine
Defined daily dose: 0.18 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 2

gtin
05909991547202
gtin
05909991547219

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for pyridostigmine.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pyridostigmine against other medicines How interaction checks work

Pyridostigmine · interactions on record

106 records

2 severe
56 moderate
48 info

Most severe, free to view

SiponimodL04AA42severe
SiponimodL04AE03severe
DicycloverineA03AA07moderate
PropanthelineA03AB05moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pyridostigmine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pyridostigmine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Mestinon
Belgium · Mestinon
Bulgaria · Калимин
Czechia · Mestinon
Germany · Amindan, Kalymin
Denmark · Mestinon, Pyridostigminbromid Orifarm
Estonia · Kalymin, Mestinon
Spain · Mestinon
Finland · Mestinon
France · Mestinon, Mestinon Lp
United Kingdom (Northern Ireland) · Mestinon, Pyridostigmine Bromide
Greece · Mestinon
Croatia · Mestinon 60
Hungary · Mestinon
Ireland · Mestinon
Italy · Mestinon
Luxembourg · Mestinon
Latvia · Kalymin 60 N, Mestinon
Malta · Mestinon
Netherlands · Mestinon, Mestinon 60
Norway · Mestinon
Portugal · Mestinon
Romania · Mestinon
Sweden · Mestinon, Pyridostigmin Orifarm
Slovenia · Mestinon
Slovakia · Mestinon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ab993628-da84-44e9-9e84-90b024835389
GET /v1/drugs/ab993628-da84-44e9-9e84-90b024835389?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "60 mg",
  "packaging": "05909991547202 ¦ Rp ¦ 156586\n50 tabl.\n05909991547219 ¦ Rp ¦ 156587\n100 tabl.",
  "substance": "Pyridostigmini bromidum 60 mg",
  "common_name": "Pyridostigmini bromidum",
  "pl_product_id": "100475890",
  "pozwolenie_nr": "28456",
  "auth_procedure": "DCP",
  "authorisation_validity": "2029-06-06"
}

API reference MCP server Plans

See everything about pyridostigmine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console